No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Patient-Reported Outcome Results from Phase 3 Study Support Concizumab Prophylaxis
A Phase 3 study sponsored by Novo Nordisk and published in Research and Practice in Thrombosis and Haemostasis found that once-daily concizumab prophylaxis significantly improved patient-reported outcomes (PROs) in individuals with hemophilia A or B with inhibitors...